Provided by Tiger Trade Technology Pte. Ltd.

Lexeo Therapeutics

3.32
-0.0650-1.92%
Volume:181.16K
Turnover:606.23K
Market Cap:271.98M
PE:-2.89
High:3.44
Open:3.38
Low:3.30
Close:3.38
52wk High:10.99
52wk Low:2.98
Shares:82.05M
Float Shares:51.23M
Volume Ratio:0.37
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1457
EPS(LYR):-1.8634
ROE:-46.76%
ROA:-27.59%
PB:1.16
PE(LYR):-1.78

Loading ...

Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2025

Major Issues Report

Form 8-K - Current report
Jun 30, 2025

Major Issues Report

Form 8-K - Current report
Jun 27, 2025

Correspondence

Form CORRESP - Correspondence
Jun 26, 2025

Correspondence

Form CORRESP - Correspondence
May 27, 2025

Major Issues Report

Form 8-K - Current report
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2025

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
May 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2025

Major Issues Report

Form 8-K - Current report
Apr 07, 2025

Major Issues Report

Form 8-K - Current report
Mar 25, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 24, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 24, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 24, 2025

Major Issues Report

Form 8-K - Current report